Testing effectiveness (Phase 2)Looking for participantsNCT07155174
What this trial is testing
Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Who this might be right for
Small Cell Lung Cancer
AbbVie 180